Increased circulating inflammatory markers may indicate that formula-fed children are at risk of atherosclerosis

Renata Roszkowska1, Katarzyna Taranta-Janusz, Edyta Tenderenda-Banasiuk

  • 1Department of Paediatrics and Nephrology, Medical University of Bialystok, Bialystok, Poland.

Insights

Formula-fed infants show elevated monocyte chemoattractant protein-1 (MCP-1) and uric acid levels compared to breastfed infants. These inflammatory markers correlate with shorter breastfeeding duration, suggesting potential health risks.

Area of Science:

  • Pediatrics
  • Immunology
  • Nutrition

Background:

  • Infant feeding practices significantly impact early-life development.
  • Inflammatory markers play a crucial role in long-term health outcomes.
  • Monocyte chemoattractant protein-1 (MCP-1) and uric acid are key indicators of inflammation.

Purpose of the Study:

  • To compare serum MCP-1 and uric acid levels in formula-fed versus breast-fed children.
  • To investigate the association between breastfeeding duration and these inflammatory markers.
  • To assess potential early indicators of atherosclerosis risk in infants.

Main Methods:

  • A cohort of 87 children aged 5-32 months was studied.
  • Participants were categorized into breast-fed and formula-fed groups.
  • Serum MCP-1 and uric acid levels were measured using ELISA and colorimetric methods, respectively.

Main Results:

  • Formula-fed children exhibited significantly higher serum MCP-1 and uric acid levels than breast-fed children.
  • Serum MCP-1 and uric acid levels were negatively correlated with the duration of breastfeeding.
  • A positive correlation was observed between serum MCP-1 and uric acid concentrations.

Conclusions:

  • Formula feeding may be associated with increased circulating inflammatory markers in infants.
  • Elevated inflammatory markers in formula-fed infants could indicate a higher risk for atherosclerosis.
  • Further research is warranted to confirm these findings and explore long-term implications.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
31
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
33
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
53
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
751
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
15.7K